DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

MR-conditional labeling now available for Abbotts Infinity DBS system First FDA-cleared MR-conditional directional DBS system

Boston Scientific to acquire TAVR protection system with purchase of Claret Medical Will acquire ownership of the Sentinel System

Viz.ai to extend LVO AI-based platform beyond stroke Using $21 million from Series A funding to do so

Fewer ICDs are failing to comply with CMS NCD standards, says study Follows DOJ investigation into overuse of non-NCD-compliant ICDs

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Ivor Benjamin American Heart Association seats new president and officers as chairman enters 2nd of two-year term

A new tool may predict the
risk of 30-day readmissions among
TAVR patients

New tool predicts readmission among TAVR patients

John R. Fischer , Staff Reporter
Thirty day readmission rates for TAVR patients may soon become predictable events among providers equipped with a new risk scoring tool.

That’s what researchers behind a study on the device claimed in their findings at the Society of Cardiovascular Angiography and Interventions 2018 Scientific Sessions, elaborating on its ability to score a patient’s risk of being readmitted following TAVR procedures.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"The creation of this tool and the results of the study are very assuring because it allows for better understanding of how patients should be managed peri-TAVR,” lead author Sahil Khera, a clinical and research fellow of interventional cardiology at Massachusetts General Hospital, said in a statement. “By recognizing patients at higher risk of readmission, we can guide post discharge care coordination and improve transitions of care to decrease readmission, improve quality of life, reduce healthcare costs and ultimately impact mortality rates.”

More than five million Americans are diagnosed with heart valve disease annually. Of those that undergo TAVR, nearly 15-20 percent are readmitted within 30 days, affecting positive outcomes, and together, racking up more than $40 billion in hospital costs annually.

The tool provides clinicians and medical professionals with a score to determine which patients are most at risk to be readmitted within 30 days. Probability scores are based on complex survey methods, hierarchical regression and the "rms" library.

The study examined 39,305 patients from the Nationwide Readmissions Database who underwent endovascular TAVR from January 2013 to September 2015 with researchers performing an international calibration with bootstrapping.

The final risk tool took into consideration chronic kidney disease, end stage renal disease on dialysis, anemia, chronic lung disease, chronic liver disease, atrial fibrillation, lengths of stay for more than five days, acute kidney injury, and discharge disposition.

Researchers recorded a score of 212 associated, with a readmission rate of more than 30 percent. Of the initial number of patients, 6,380 patients were readmitted within 30 days, a rate of 16.2 percent. The c-statistic of the model was 0.63.

"Use of the simple risk tool will allow the entire care team to quantify readmission risk and enhance our ability to provide personalized transitional care to hopefully mitigate this risk," said co-author Sammy Elmariah, director of interventional structural heart disease at Massachusetts General Hospital, in a statement.

The authors hope to begin using and incorporating the tools in hospital EMRs nationwide.

Cardiology Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有